Zhengye Biotechnology Holding (ZYBT) Payables (2023 - 2025)
Historic Payables for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $17.1 million.
- Zhengye Biotechnology Holding's Payables changed N/A to $17.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $17.1 million, marking a year-over-year change of. This contributed to the annual value of $16.3 million for FY2024, which is 1820.68% down from last year.
- As of Q2 2025, Zhengye Biotechnology Holding's Payables stood at $17.1 million.
- Zhengye Biotechnology Holding's Payables' 5-year high stood at $19.6 million during Q4 2023, with a 5-year trough of $16.3 million in Q4 2024.
- In the last 3 years, Zhengye Biotechnology Holding's Payables had a median value of $17.1 million in 2025 and averaged $17.7 million.
- Examining YoY changes over the last 5 years, Zhengye Biotechnology Holding's Payables showed a top increase of 1663.97% in 2024 and a maximum decrease of 1663.97% in 2024.
- Over the past 3 years, Zhengye Biotechnology Holding's Payables (Quarter) stood at $19.6 million in 2023, then dropped by 16.64% to $16.3 million in 2024, then grew by 4.6% to $17.1 million in 2025.
- Its Payables was $17.1 million in Q2 2025, compared to $16.3 million in Q4 2024 and $19.6 million in Q4 2023.